Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...
For educated yet unemployed youth struggling to find work, a government support scheme has emerged as a major relief. The ...